Literature DB >> 12696896

Investigations of bivalent antibody binding on fluid-supported phospholipid membranes: the effect of hapten density.

Tinglu Yang1, Olga K Baryshnikova, Hanbin Mao, Matthew A Holden, Paul S Cremer.   

Abstract

Investigations of ligand-receptor binding between bivalent antibodies and membrane-bound ligands are presented. The purpose of these studies was to explore binding as a function of hapten density in a two-dimensionally fluid environment. A novel microfluidic strategy in conjunction with total internal reflection fluorescence microscopy was designed to achieve this. The method allowed binding curves to be acquired with excellent signal-to-noise ratios while using only minute quantities of protein solution. The specific system investigated was the interaction between anti-DNP antibodies and phospholipid membranes containing DNP-conjugated lipids. Binding curves for ligand densities ranging from 0.1 to 5.0 mol % were obtained. Two individual dissociation constants could be extracted from the data corresponding to the two sequential binding events. The first dissociation constant, K(D1), was 2.46 x 10(-)(5) M, while the second was K(D2) = 1.37 x 10(-)(8) mol/m(2). This corresponded to a positively cooperative binding effect with an entropic difference between the two events of 62.3 +/- 2.7 J/(mol.K). Furthermore, the percentage of monovalently and bivalently bound protein was determined at each ligand density.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12696896     DOI: 10.1021/ja029469f

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  29 in total

1.  Following single antibody binding to purple membranes in real time.

Authors:  Ferry Kienberger; Harald Mueller; Vassili Pastushenko; Peter Hinterdorfer
Journal:  EMBO Rep       Date:  2004-05-14       Impact factor: 8.807

2.  Single-molecule studies of synaptotagmin and complexin binding to the SNARE complex.

Authors:  Mark E Bowen; Keith Weninger; James Ernst; Steven Chu; Axel T Brunger
Journal:  Biophys J       Date:  2005-04-08       Impact factor: 4.033

3.  Determination of the two-dimensional interaction rate constants of a cytokine receptor complex.

Authors:  Martynas Gavutis; Eva Jaks; Peter Lamken; Jacob Piehler
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

4.  GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes.

Authors:  Jinjun Shi; Tinglu Yang; Sho Kataoka; Yanjie Zhang; Arnaldo J Diaz; Paul S Cremer
Journal:  J Am Chem Soc       Date:  2007-04-13       Impact factor: 15.419

5.  Quantitative fluorescence microscopy using supported lipid bilayer standards.

Authors:  William J Galush; Jeffrey A Nye; Jay T Groves
Journal:  Biophys J       Date:  2008-05-30       Impact factor: 4.033

6.  Using covalent dimers of human carbonic anhydrase II to model bivalency in immunoglobulins.

Authors:  Eric T Mack; Phillip W Snyder; Raquel Perez-Castillejos; George M Whitesides
Journal:  J Am Chem Soc       Date:  2011-07-07       Impact factor: 15.419

7.  Supported lipopolymer membranes as nanoscale filters: simultaneous protein recognition and size-selection assays.

Authors:  Fernando Albertorio; Susan Daniel; Paul S Cremer
Journal:  J Am Chem Soc       Date:  2006-06-07       Impact factor: 15.419

8.  Microfluidic fabrication of asymmetric giant lipid vesicles.

Authors:  Peichi C Hu; Su Li; Noah Malmstadt
Journal:  ACS Appl Mater Interfaces       Date:  2011-04-11       Impact factor: 9.229

9.  Stoichiometry controls activity of phase-separated clusters of actin signaling proteins.

Authors:  Lindsay B Case; Xu Zhang; Jonathon A Ditlev; Michael K Rosen
Journal:  Science       Date:  2019-03-08       Impact factor: 47.728

10.  Lipid bilayer composition can influence the orientation of proteorhodopsin in artificial membranes.

Authors:  Ramya Tunuguntla; Mangesh Bangar; Kyunghoon Kim; Pieter Stroeve; Caroline M Ajo-Franklin; Aleksandr Noy
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.